Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,549 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 386
Recruiting: 215
Ph III recruiting: 36
Growth YoY: +9.8%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 29.9 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 101–150 of 1,549 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05526079	Watchful Waiting for Complete Responders to Therapy in Rectal Cancer	terminated	N/A	15	Henry Ford Health SystemOTHER	1	Jul 23, 2026	clinicaltrials
NCT06834126	Papaverine in Combination With Radiation Therapy for the Treatment of Locally Advanced Rectal Cancer, DINOMITE Trial	recruiting	Phase 1	36	City of Hope Medical CenterOTHER	1	Jul 22, 2026	clinicaltrials